Skip to main content
. Author manuscript; available in PMC: 2014 Apr 4.
Published in final edited form as: Metab Brain Dis. 2014 Mar;29(1):37–45. doi: 10.1007/s11011-013-9440-0

Fig. 1.

Fig. 1

DRα1-MOG-35-55 treatment decreased infarct size compared to vehicle 96 h after MCAO. a Infarct volumes were significantly decreased in DRα1-MOG-35-55 (n =10) versus Vehicle-treated (n =10) mice after 60 min MCAO and 96 h of reperfusion in cortex (CTX) and caudateputamen (CP), as well as in total hemisphere (HMSPHR) (*p ≤0.05). B). Representative 2,3,5-triphenyltetrazolium chloride stained cerebral sections after 96 h of reperfusion following 1 h of MCAO